- Home
- ZAPP vs FBRX Comparison
ZAPP vs FBRX Comparison
Compare ZAPP & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZAPP
- FBRX
- Stock Information
- Founded
- ZAPP 2017
- FBRX N/A
- Country
- ZAPP Thailand
- FBRX United States
- Employees
- ZAPP N/A
- FBRX N/A
- Industry
- ZAPP Motor Vehicles
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ZAPP Consumer Discretionary
- FBRX Health Care
- Exchange
- ZAPP Nasdaq
- FBRX Nasdaq
- Market Cap
- ZAPP 8.3M
- FBRX 8.3M
- IPO Year
- ZAPP N/A
- FBRX N/A
- Fundamental
- Price
- ZAPP $1.79
- FBRX $5.60
- Analyst Decision
- ZAPP
- FBRX Strong Buy
- Analyst Count
- ZAPP 0
- FBRX 3
- Target Price
- ZAPP N/A
- FBRX $81.25
- AVG Volume (30 Days)
- ZAPP 89.5K
- FBRX 12.9K
- Earning Date
- ZAPP 11-19-2024
- FBRX 11-22-2024
- Dividend Yield
- ZAPP N/A
- FBRX N/A
- EPS Growth
- ZAPP N/A
- FBRX N/A
- EPS
- ZAPP N/A
- FBRX N/A
- Revenue
- ZAPP N/A
- FBRX N/A
- Revenue This Year
- ZAPP N/A
- FBRX N/A
- Revenue Next Year
- ZAPP $53,347.33
- FBRX N/A
- P/E Ratio
- ZAPP N/A
- FBRX N/A
- Revenue Growth
- ZAPP N/A
- FBRX N/A
- 52 Week Low
- ZAPP $0.70
- FBRX $4.11
- 52 Week High
- ZAPP $19.10
- FBRX $21.25
- Technical
- Relative Strength Index (RSI)
- ZAPP 29.06
- FBRX 59.65
- Support Level
- ZAPP $1.62
- FBRX $4.44
- Resistance Level
- ZAPP $2.08
- FBRX $5.90
- Average True Range (ATR)
- ZAPP 0.19
- FBRX 0.37
- MACD
- ZAPP 0.00
- FBRX 0.20
- Stochastic Oscillator
- ZAPP 24.25
- FBRX 82.36
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).